Lack of improvement in outpatient management of congestive heart failure in the United States.
作者信息
Banerjee Dipanjan, Stafford Randall S
出版信息
Arch Intern Med. 2010 Aug 9;170(15):1399-400. doi: 10.1001/archinternmed.2010.270.
Abstract
摘要
相似文献
1
Lack of improvement in outpatient management of congestive heart failure in the United States.美国充血性心力衰竭门诊管理未见改善。
Arch Intern Med. 2010 Aug 9;170(15):1399-400. doi: 10.1001/archinternmed.2010.270.
2
Outpatient management of heart failure in the United States, 2006-2008.2006 - 2008年美国心力衰竭的门诊管理
Tex Heart Inst J. 2014 Jun 1;41(3):253-61. doi: 10.14503/THIJ-12-2947. eCollection 2014 Jun.
3
Use of guideline-recommended therapies for heart failure in the Medicare population.在 Medicare 人群中使用指南推荐的心力衰竭治疗方法。
Clin Cardiol. 2010 Jul;33(7):400-5. doi: 10.1002/clc.20760.
4
[Treatment of heart failure and preserved systolic function].[射血分数保留的心力衰竭的治疗]
Lakartidningen. 2007;104(34):2348-50.
5
Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.在加拿大艾伯塔省，心力衰竭患者出院后开具β受体阻滞剂和血管紧张素转换酶抑制剂/受体阻滞剂与死亡率降低相关。
J Am Coll Cardiol. 2003 Oct 15;42(8):1438-45. doi: 10.1016/s0735-1097(03)01058-1.
6
Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.在一家以学术医院为基础的老年医学实践中，老年患者使用地高辛、利尿剂、β受体阻滞剂、血管紧张素转换酶抑制剂和钙通道阻滞剂的情况。
J Am Geriatr Soc. 1997 Jul;45(7):809-12. doi: 10.1111/j.1532-5415.1997.tb01506.x.
7
Management of chronic heart failure: an old disease with a new face.慢性心力衰竭的管理：旧病新貌
Emerg Med Australas. 2005 Apr;17(2):143-51. doi: 10.1111/j.1742-6723.2005.00707.x.
8
Halting the progression of heart failure: finding the optimal combination therapy.
Cleve Clin J Med. 2002 Feb;69(2):104-5, 109-10, 112. doi: 10.3949/ccjm.69.2.104.
9
Recent developments in the pharmacotherapy of cardiac failure.
Med J Aust. 1992 Sep 7;157(5):292-4. doi: 10.5694/j.1326-5377.1992.tb137175.x.
10
Impact of restrictive prescription plans on heart failure medication use.限制性处方计划对心力衰竭药物使用的影响。
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):484-90. doi: 10.1161/CIRCOUTCOMES.108.804351. Epub 2009 Sep 1.
引用本文的文献
1
Physician Financial Incentives to Reduce Unplanned Hospital Readmissions: an Interrupted Time Series Analysis.医生减少非计划性住院再入院的经济激励措施：一项中断时间序列分析。
J Gen Intern Med. 2021 Nov;36(11):3431-3440. doi: 10.1007/s11606-021-06803-8. Epub 2021 May 4.
2
Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information.使用安慰剂对照的心力衰竭中β受体阻滞剂的真实与虚假副作用的系统评价：患者信息的建议。
Int J Cardiol. 2013 Oct 9;168(4):3572-9. doi: 10.1016/j.ijcard.2013.05.068. Epub 2013 Jun 21.
本文引用的文献
1
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2009年心脏病和中风统计数据更新：美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2009 Jan 27;119(3):480-6. doi: 10.1161/CIRCULATIONAHA.108.191259.
2
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.1986年至2003年间心力衰竭首次住院的长期趋势及后续生存率：一项对510万人的人群研究。
Circulation. 2009 Feb 3;119(4):515-23. doi: 10.1161/CIRCULATIONAHA.108.812172. Epub 2009 Jan 19.
3
Evidence-based cardiovascular care in the community: a population-based cross-sectional study.社区中基于证据的心血管护理：一项基于人群的横断面研究。
BMC Fam Pract. 2004 Apr 1;5:6. doi: 10.1186/1471-2296-5-6.
4
Treatment gaps in the pharmacologic management of heart failure.心力衰竭药物治疗中的治疗差距。
Rev Cardiovasc Med. 2002;3 Suppl 3:S11-9.
5
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.卡维地洛对重度慢性心力衰竭患者发病率的影响：卡维地洛前瞻性随机累积生存（COPERNICUS）研究结果
Circulation. 2002 Oct 22;106(17):2194-9. doi: 10.1161/01.cir.0000035653.72855.bf.
Zotero 插件